The Ozempic Expert: Ozempic Transforms Your Gut Microbiome! People Are Being Overdosed On Ozempic!
A long interview in which a naturopathic physician explains why she uses very low doses of semaglutide, how she says standard dosing differs, and what lifestyle steps she pairs with it.
With Dr. Tina Moore (naturopathic physician and chiropractor), Diary of a CEO host (not named in the transcript)
Key moments
Tap a moment to play the video from there.
- 2:06Moore's background and approachMoore describes naturopathic training and her focus on root causes, and says she took over a mentor's musculoskeletal practice built on regenerative injections.
- 6:39Defining metabolic dysfunctionShe defines metabolic dysfunction as a failure to process food properly, and says it leads to insulin resistance and eventually type 2 diabetes.
- 15:20Her mother's low-dose semaglutideMoore says she put her mother on a very small amount of semaglutide after a Crohn's disease episode and describes improvements in joints, gut and cognition.
- 20:24Searching GLP-1 and neuroinflammationShe recounts her own psoriatic arthritis pain and says a search on GLP-1 and neural inflammation led her to start researching these drugs.
- 29:05Why she says doses are too highShe argues the standard 16-week escalation overdoses many people and explains peptides and how semaglutide mimics GLP-1.
- 36:13Her own experience microdosingMoore describes starting at a tiny dose, noticing clearer thinking, less anxiety and less pain, and cycling the drug now.
- 43:19Studies she citesShe points to the SELECT and FLOW trials and other data she says show benefits beyond weight loss, and discusses lean mass loss.
- 1:12:24Dose demonstration on setShe shows the pen starting dose and the escalated dose, explains using an insulin syringe for fractions, and describes her cycling schedules.
- 1:24:06Dopamine, food noise and addictionMoore and the host discuss how she believes GLP-1 quiets food noise and reward-seeking behaviors through dopamine pathways.
- 1:30:39Safety and informed consentShe argues high doses carry the main risks, and says patients should be monitored, informed and not self-dose.
What the video says
This is a long, wide-ranging health interview on The Diary of a CEO. Guest Dr. Tina Moore, a naturopathic physician and chiropractor, covers her background, her own chronic pain, and her views on food, toxins and lifestyle. The peptide content centres on semaglutide, which she calls Ozempic, and her practice of using it at very small doses.
Moore explains peptides in simple terms and says semaglutide is a modified version of the GLP-1 hormone the body makes in the gut and brain. She says she began researching GLP-1 drugs while looking for ways to calm neuroinflammation, and that she started herself on a tiny dose. She reports that brain fog and anxiety eased within days and that her pain fell over the following weeks. She describes similar responses in her mother and in patients, and says she cycles the drug the way she would a hormone. All of this is her own account and clinical impression.
A large part of the talk is her argument that the standard escalation, from 0.25 mg to 2.5 mg per week over 16 weeks, is too aggressive. She says high doses crush appetite, raise the risk of side effects such as gallbladder and pancreas problems, and push people to eat less of a poor diet. She says she dosed one patient up to roughly 1 mg over nine months and prefers to keep doses just below symptoms. She also discusses muscle loss, which she attributes mostly to calorie restriction and to how lean mass is measured. She cites trials and data sets on cardiovascular, kidney and cancer outcomes, which she presents as supportive of benefits beyond weight loss.
The host is openly curious but cautious. He says he will not try this himself and urges viewers to check studies and talk to a doctor. Moore says she is not giving exact doses publicly. Her non-drug advice includes strength training, protein, daily walks in daylight, sleep habits and heat exposure. She briefly mentions BPC-157 as an over-the-counter peptide.
On each compound
Semaglutide29:05
Moore, who calls it Ozempic, says semaglutide mimics the body's GLP-1 and that she uses fractions of the 0.25 mg starting dose, cycled and combined with lifestyle changes. She says the standard escalation to 2.5 mg per week is too aggressive and reports benefits in herself, her mother and patients, which are her own accounts.
See how your DNA reads SemaglutideBPC-1571:11:00
Moore mentions BPC-157 in passing as an over-the-counter peptide she describes as regenerative and anti-inflammatory, and says people can buy it online in supplement form.
See how your DNA reads BPC-157What this video doesn’t settle
- The microdosing approach is described through Moore's own experience, her mother and her patients, with no control group or published dosing data presented.
- Moore says she will not give exact doses, so the video does not establish what a low dose actually is for any person.
- The host raises long-term safety of microdosing, and Moore answers by extrapolating from high-dose data rather than citing studies of low doses.
Questions this video answers
What does Dr. Tina Moore mean by microdosing Ozempic?
She says it means using a fraction of the 0.25 mg starting dose, measured with an insulin syringe, often cycled with time off. She says her aim is to dose just below symptoms, and that the dose varies by patient.
Why does Moore say standard semaglutide dosing is a problem?
She says the pen schedule rises from 0.25 mg to 2.5 mg per week over 16 weeks, which she believes crushes appetite and raises the chance of side effects. She links gastrointestinal, gallbladder and pancreas problems to high doses and rapid weight loss.
What does Moore say about muscle loss on semaglutide?
She argues that muscle loss comes mainly from severe calorie restriction rather than from GLP-1 drugs, and that studies lump all lean mass together. She says strength training and protein are non-negotiable for anyone taking it.
What lifestyle steps does Moore pair with low-dose semaglutide?
She lists strength training a couple of times a week, prioritizing protein, three 10-minute daily walks in daylight, protected sleep, and heat exposure such as a sauna or bath. She says these matter more than the drug.
Does the host recommend microdosing Ozempic?
No. The host says he is intrigued but will not try it himself, and urges viewers to read the studies and speak to a doctor. He frames the idea as an early hypothesis.
Video by The Diary Of A CEO on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
